Reaction Details |
| Report a problem with these data |
Target | Tyrosine-protein kinase receptor UFO |
---|
Ligand | BDBM50269382 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1706542 (CHEMBL4057775) |
---|
EC50 | 216±n/a nM |
---|
Citation | Goff, D; Zhang, J; Heckrodt, T; Yu, J; Ding, P; Singh, R; Holland, S; Li, W; Irving, M Discovery of dual Axl/VEGF-R2 inhibitors as potential anti-angiogenic and anti-metastatic drugs for cancer chemotherapy. Bioorg Med Chem Lett27:3766-3771 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Tyrosine-protein kinase receptor UFO |
---|
Name: | Tyrosine-protein kinase receptor UFO |
Synonyms: | AXL | AXL oncogene | TEL/AXL | Tyrosine-protein kinase receptor UFO (AXL) | UFO | UFO_HUMAN |
Type: | Enzyme |
Mol. Mass.: | 98316.97 |
Organism: | Homo sapiens (Human) |
Description: | P30530 |
Residue: | 894 |
Sequence: | MAWRCPRMGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQLQV
QGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSLQLSDTGQYQCLVF
LGHQTFVSQPGYVGLEGLPYFLEEPEDRTVAANTPFNLSCQAQGPPEPVDLLWLQDAVPL
ATAPGHGPQRSLHVPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTE
LEVAWTPGLSGIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLH
PHTPYHIRVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPRAPL
QGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVAAYTAAGDGPWSLP
VPLEAWRPGQAQPVHQLVKEPSTPAFSWPWWYVLLGAVVAAACVLILALFLVHRRKKETR
YGEVFEPTVERGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGK
TLGEGEFGAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRL
IGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIASGM
EYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES
LADRVYTSKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPADCLDGLYA
LMSRCWELNPQDRPSFTELREDLENTLKALPPAQEPDEILYVNMDEGGGYPEPPGAAGGA
DPPTQPDPKDSCSCLTAAEVHPAGRYVLCPSTTPSPAQPADRGSPAAPGQEDGA
|
|
|
BDBM50269382 |
---|
n/a |
---|
Name | BDBM50269382 |
Synonyms: | CHEMBL4071540 |
Type | Small organic molecule |
Emp. Form. | C26H29Cl2N9S |
Mol. Mass. | 570.54 |
SMILES | [H][C@]12CC[C@]([H])(C1)[C@@H](C2)N1CCN(CC1)c1ccc(Nc2nc(N)n(n2)-c2nc(Cl)nc3c(C)csc23)cc1Cl |r,THB:9:7:2.3:6| |
Structure |
|